Resmed Inc (RMD)
NYSE:RMD
Want to see RMD full AI Analyst Report?
Total Valuation
Resmed has a market cap or net worth of $30.44B. The enterprise value is $29.62B.
Market Cap$30.44B
Enterprise Value$29.62B
Share Statistics
Resmed has 145,056,380 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding145,056,380
Owned by Insiders0.53%
Owned by Institutions11.11%
Financial Efficiency
Resmed’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 19.56%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)19.56%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee515.66K
Profits Per Employee140.35K
Employee Count9,980
Asset Turnover0.63
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of Resmed is 20.6. Resmed’s PEG ratio is 0.72.
PE Ratio20.6
PS Ratio7.36
PB Ratio6.34
Price to Fair Value6.34
Price to FCF22.78
Price to Operating Cash Flow16.26
PEG Ratio0.72
Income Statement
In the last 12 months, Resmed had revenue of 5.15B and earned 1.40B in profits. Earnings per share was 9.55.
Revenue5.15B
Gross Profit3.05B
Operating Income1.69B
Pretax Income1.68B
Net Income1.40B
EBITDA1.91B
Earnings Per Share (EPS)9.55
Cash Flow
In the last 12 months, operating cash flow was 1.89B and capital expenditures -135.74M, giving a free cash flow of 1.75B billion.
Operating Cash Flow1.89B
Free Cash Flow1.75B
Free Cash Flow per Share12.09
Dividends & Yields
Resmed pays an annual dividend of $0.6, resulting in a dividend yield of 0.92%
Dividend Per Share$0.6
Dividend Yield0.92%
Payout Ratio22.83%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-13.78%
50-Day Moving Average219.35
200-Day Moving Average250.03
Relative Strength Index (RSI)47.16
Average Volume (3m)1.30M
Important Dates
Resmed upcoming earnings date is Jul 30, 2026, After Close (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Resmed as a current ratio of 3.44, with Debt / Equity ratio of 12.99%
Current Ratio3.44
Quick Ratio2.53
Debt to Market Cap0.02
Net Debt to EBITDA-0.19
Interest Coverage Ratio133.66
Taxes
In the past 12 months, Resmed has paid 276.84M in taxes.
Income Tax276.84M
Effective Tax Rate0.17
Enterprise Valuation
Resmed EV to EBITDA ratio is 19.60, with an EV/FCF ratio of 22.56.
EV to Sales7.29
EV to EBITDA19.60
EV to Free Cash Flow22.56
EV to Operating Cash Flow21.41
Balance Sheet
Resmed has $1.66B in cash and marketable securities with $843.17M in debt, giving a net cash position of $817.34M billion.
Cash & Marketable Securities$1.66B
Total Debt$843.17M
Net Cash$817.34M
Net Cash Per Share$5.63
Tangible Book Value Per Share$16.74
Margins
Gross margin is 61.69%, with operating margin of 32.75%, and net profit margin of 27.22%.
Gross Margin61.69%
Operating Margin32.75%
Pretax Margin32.60%
Net Profit Margin27.22%
EBITDA Margin37.18%
EBIT Margin32.60%
Analyst Forecast
The average price target for Resmed is $264.56, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$264.56
Price Target Upside15.97% Upside
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast10.28%
EPS Growth Forecast16.40%